Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Vitiligo: a review
Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of
the population worldwide. The disease is characterized by the selective loss of melanocytes …
the population worldwide. The disease is characterized by the selective loss of melanocytes …
Vitiligo: mechanisms of pathogenesis and treatment
Vitiligo is an autoimmune disease of the skin that targets pigment-producing melanocytes
and results in patches of depigmentation that are visible as white spots. Recent research …
and results in patches of depigmentation that are visible as white spots. Recent research …
Vitiligo: a focus on pathogenesis and its therapeutic implications
Vitiligo is the most common depigmenting disorder affecting 0.1%–2% of the population
worldwide. The characteristic white patches result from the selective loss of melanocytes …
worldwide. The characteristic white patches result from the selective loss of melanocytes …
Vitiligo, from pathogenesis to therapeutic advances: state of the art
F Diotallevi, H Gioacchini, E De Simoni… - International Journal of …, 2023 - mdpi.com
Vitiligo is an acquired hypopigmentation of the skin due to a progressive selective loss of
melanocytes; it has a prevalence of 1–2% and appears as rounded, well-demarcated white …
melanocytes; it has a prevalence of 1–2% and appears as rounded, well-demarcated white …
Vitiligo pathogenesis and emerging treatments
Vitiligo is a common, disfiguring autoimmune disease that negatively affects patients' self-
esteem and quality of life. 1, 2 Existing vitiligo treatments, which are used off-label, are …
esteem and quality of life. 1, 2 Existing vitiligo treatments, which are used off-label, are …
Skin pigmentation and its control: From ultraviolet radiation to stem cells
JM Yardman‐Frank, DE Fisher - Experimental dermatology, 2021 - Wiley Online Library
In the light of substantial discoveries in epithelial and hair pigmentation pathophysiology,
this review summarizes the current understanding of skin pigmentation mechanisms …
this review summarizes the current understanding of skin pigmentation mechanisms …
Vitiligo: an update on pathophysiology and treatment options
R Speeckaert, N van Geel - American journal of clinical dermatology, 2017 - Springer
The pathophysiology of vitiligo is becoming increasingly clarified. In non-segmental vitiligo,
early factors include activation of innate immunity, inflammasome activation, oxidative stress …
early factors include activation of innate immunity, inflammasome activation, oxidative stress …
Current and emerging treatments for vitiligo
Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are
safe and effective treatments available for vitiligo. It is important to recognize common and …
safe and effective treatments available for vitiligo. It is important to recognize common and …
British Association of Dermatologists guidelines for the management of people with vitiligo 2021
V Eleftheriadou, R Atkar, J Batchelor… - British Journal of …, 2022 - academic.oup.com
British Association of Dermatologists guidelines for the management of people with vitiligo 2021*
| British Journal of Dermatology | Oxford Academic Skip to Main Content Advertisement intended …
| British Journal of Dermatology | Oxford Academic Skip to Main Content Advertisement intended …
[HTML][HTML] Vitiligo: pathogenesis and new and emerging treatments
Vitiligo is a complex disease with a multifactorial nature and a high impact on the quality of
life of patients. Although there are multiple therapeutic alternatives, there is currently no fully …
life of patients. Although there are multiple therapeutic alternatives, there is currently no fully …